Extramedullary infiltration in pediatric acute myeloid leukemia: Results of the Therapeutically Applicable Research to Generate Effective Treatments dataset
Weiya Li1#, Mingyue Shi1#, Pan Zhou1, Ying Liu1, Xiaobo Liu1, Xingjun Xiao1, Suqiong Zuo1, Yanliang Bai1, Kai Sun1, 2*
1 Department of Hematology, Zhengzhou University People’s Hospital and Henan Provincial People’s Hospital, Henan, People’s Republic of China;
2 Department of Hematology, Beijing JiShuiTan Hospital, Capital Medical University, Beijing, China.
* Correspondence to:
Prof. Kai Sun, M.D., Ph.D., Department of Hematology, Zhengzhou University People’s Hospital and Henan Provincial People’s Hospital, No.7 Weiwu Road, Jinshui District Zhengzhou, Henan 450003, People’s Republic of China; Email:sunkai@cellscience.org.
# These authors contributed equally to this work.
Text word count: 3173 characters.
Abstract word count: 250 characters.
The number of tables: 3.
The number of figures: 2.
Brief Running title: EMI in pediatric AML: results of TARGET dataset
Keywords: Pediatric acute myeloid leukemia; Extramedullary infiltration; Initial diagnosis; Relapse; Prognosis; Gemtuzumab ozogamicin